What question did this study set out to answer?

To compare therapeutic responses between eosinophilic and neutrophilic endotypes of chronic rhinosinusitis using murine models.

June 13, 2026

Murine Eosinophilic and Neutrophilic Chronic Rhinosinusitis Models Reveal Phenotype-Specific Steroid Responses

Key Points

To compare therapeutic responses between eosinophilic and neutrophilic endotypes of chronic rhinosinusitis using murine models.
Used female C57BL/6N mice to induce eosinophilic and neutrophilic chronic rhinosinusitis through different stimuli.
Administered dexamethasone to assess steroid responsiveness over 4 and 12 weeks.
Evaluated outcomes using flow cytometry, ELISA, quantitative PCR, histology, and immunofluorescence.
Four-week allergen exposure produced eosinophilic chronic rhinosinusitis with significant responsiveness to dexamethasone.
Twelve-week exposure led to mixed chronic rhinosinusitis with reduced steroid efficacy and predominant neutrophilic characteristics.
Innate stimuli-induced neutrophilic rhinosinusitis showed a steroid-resistant phenotype with minimal type-2 biomarkers.

Abstract

Background Chronic rhinosinusitis (CRS) comprises heterogeneous eosinophilic (type-2) and neutrophilic (type-1/3) endotypes, yet existing murine models rarely distinguish them or compare their therapeutic responsiveness. Methods Seven-week-old female C57BL/6N mice received intranasal instillations three times weekly for 4 or 12 weeks with either (1) a clinically relevant airborne allergen cocktail (house dust mite HDM, Aspergillus fumigatus, Alternaria alternata, and Staphylococcus aureus protease) to induce eosinophilic CRS (ECRS) or (2) an innate stimulus mixture (lipopolysaccharide, β-1,3-glucan, and S. aureus protease) to induce neutrophilic CRS (NCRS). A parallel cohort received weekly dexamethasone administration (2 mg/kg). Endpoints included flow cytometry, enzyme-linked immunosorbent assays, quantitative PCR, histology, and immunofluorescence assays. Results Four-week allergen exposure produced a pure ECRS phenotype characterized by robust tissue eosinophilia, type-2 cytokines, and marked responsiveness to dexamethasone. Extending allergen delivery to 12 weeks generated mixed CRS with superimposed neutrophilia, upregulation of Il1b/Tgfb1 , mucus hypersecretion, and attenuated steroid efficacy. Innate stimulus treatment yielded a steroid-resistant NCRS phenotype dominated by neutrophils, elevated Ifng/Il17a expression, and minimal type-2 biomarkers. Systemic eotaxin and HDM-specific immunoglobulin E mirrored those found in local eosinophilia, whereas circulating granulocytes remained unchanged across groups. Conclusions By adjusting the stimulus type and duration, we established tunable murine models that recapitulate pure ECRS, mixed CRS, and steroid-resistant NCRS within a single genetic background. These paired models provide a versatile platform for dissecting endotype-specific mechanisms and evaluating tailored interventions, highlighting the potential importance of early, phenotype-directed CRS therapy.

Bookmark

Cite This Study

Kang et al. (Thu,) studied this question.

synapsesocial.com/papers/6a2cf57cfaef96ed7f057803 https://doi.org/https://doi.org/10.1177/19458924261456360

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark